Trial · NCT03088813
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs) | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | Any TEAE | 5 | Participants | |
| Part 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs) | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | Any TEAE | 25 | Participants | |
| Part 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs) | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | Serious TEAEs | 4 | Participants | |
| Part 1: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs) | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | Serious TEAEs | 9 | Participants | |
| Part 1: Number of Participants With Dose-Limiting Toxicities (DLT) | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | 4 | Participants | ||
| Part 1: Number of Participants With Dose-Limiting Toxicities (DLT) | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | 2 | Participants | ||
| Part 2: Overall Survival (OS) | Part 2: Irinotecan Liposome Injection 70 mg/m^2 | 7.92 | 95% Confidence Interval 6.87 to 9.23 | months | |
| Part 2: Overall Survival (OS) | Part 2: Topotecan 1.5 mg/m^2 | 8.31 | 95% Confidence Interval 7.33 to 9.13 | months | |
| Part 1: Objective Response Rate (ORR) | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | 40 | 95% Confidence Interval 5.27 to 85.34 | percentage of participants | |
| Part 1: Objective Response Rate (ORR) | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | 44 | 95% Confidence Interval 24.40 to 65.07 | percentage of participants | |
| Part 1: Progression-Free Survival (PFS) | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | 4.19 | 95% Confidence Interval 1.58 to NA | months | |
| Part 1: Progression-Free Survival (PFS) | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | 3.98 | 95% Confidence Interval 2.69 to 4.24 | months | |
| Part 1: OS | Part 1: Irinotecan Liposome Injection 85 mg/m^2 | 10.84 | 95% Confidence Interval 0.99 to NA | months | |
| Part 1: OS | Part 1: Irinotecan Liposome Injection 70 mg/m^2 | 8.08 | 95% Confidence Interval 5.16 to 9.82 | months | |
| Part 2: PFS | Part 2: Irinotecan Liposome Injection 70 mg/m^2 | 4.01 | 95% Confidence Interval 2.96 to 4.17 | months | |
| Part 2: PFS | Part 2: Topotecan 1.5 mg/m^2 | 3.25 | 95% Confidence Interval 2.79 to 4.14 | months | |
| Part 2: ORR | Part 2: Irinotecan Liposome Injection 70 mg/m^2 | 44.1 | 95% Confidence Interval 37.57 to 50.79 | percentage of participants | |
| Part 2: ORR | Part 2: Topotecan 1.5 mg/m^2 | 21.6 | 95% Confidence Interval 16.44 to 27.41 | percentage of participants | |
| Part 2: Median Duration of Response (DoR) | Part 2: Irinotecan Liposome Injection 70 mg/m^2 | 4.14 | 95% Confidence Interval 3.06 to 4.34 | months | |
| Part 2: Median Duration of Response (DoR) | Part 2: Topotecan 1.5 mg/m2 IV | 4.17 | 95% Confidence Interval 2.86 to 4.76 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03088813/results